Literature DB >> 10225128

Methodological and clinical challenges in evaluating treatment outcome of substance-related disorders and comorbidity.

N el-Guebaly1, D C Hodgins, S Armstrong, J Addington.   

Abstract

OBJECTIVE: To review the steps required to develop an outcome evaluation package and to report on the 12-month outcome of an integrated day program.
METHOD: Based on the identification of salient outcome predictors, standardized instruments were selected. A cohort of 78 patients was assessed at the time of admission to the program, at discharge, and 3, 6, and 12 months afterward.
RESULTS: Improvements were sustained over 1 year in all areas including treatment needs, quality of life, and readiness to change.
CONCLUSIONS: The gap between the "cultures" of treatment and research must be narrowed. Following evidence of a program's general effectiveness through outcome monitoring, a randomized control design is optimal for specific interventions. The optimal length of follow-up depends on the perceived confounds.

Entities:  

Mesh:

Year:  1999        PMID: 10225128     DOI: 10.1177/070674379904400307

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  4 in total

Review 1.  Pathological gambling, comorbidities and treatment outcome: is the bronze standard good enough? A case study.

Authors:  Nady el-Guebaly
Journal:  J Gambl Stud       Date:  2005

2.  Concurrent substance-related disorders and mental illness: the North American experience.

Authors:  Nady el-Guebaly
Journal:  World Psychiatry       Date:  2004-10       Impact factor: 49.548

3.  Management of "dual diagnosis" patients : consensus, controversies and considerations.

Authors:  D Basu; N Gupta
Journal:  Indian J Psychiatry       Date:  2000-01       Impact factor: 1.759

4.  Temporal stability of the timeline followback interview for alcohol and drug use with psychiatric outpatients.

Authors:  Kate B Carey; Michael P Carey; Stephen A Maisto; James M Henson
Journal:  J Stud Alcohol       Date:  2004-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.